provider_review · verified 2026-08-04
Peter MD review
Package price for an 8-10 week supply, not a flat monthly rate
$369 buys two 200mg/ml vials sized to last 8-10 weeks; the $147-184/month figure on this row is our own division of that number, not a rate Peter MD advertises as monthly.
How this site makes money
Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.
at_a_glance
- price
- "$369" for 2 vials (200mg/ml), stated as an 8-10 week supply, printed on the NAD+ product page.
- what you pay
- Roughly $147-184/month depending on how the 8-10 week supply is used — our own division of $369 by the stated supply window, not a figure Peter MD publishes as a monthly rate.
- pharmacy
- Not named — no compounding facility or 503A/503B designation is published on the NAD+ product page.
- states
- Not published as a list on the NAD+ product page; like most compounded telehealth, Peter MD is not available in every state and coverage should be confirmed at intake.
- on our index
- Ranked #8 of 25 on our NAD+ provider index.
verdict
The short version
Peter MD sells a physician-prescribed injectable NAD+ protocol — two 200mg/ml vials for $369, sized to last 8-10 weeks — alongside a broader menu of tirzepatide, semaglutide, sermorelin and TRT for patients who want more than NAD+ from one provider. The $369 figure is printed on the product page itself, which puts it ahead of sellers who gate every number behind an intake, but it is a package price rather than a monthly one: the $147-184/month range here is arithmetic we did dividing $369 by the supply window, not a number Peter MD states as a monthly rate. The company also markets its protocol as "backed by 100+ clinical studies," a claim we treat as the company's own promotional language rather than a citation we could verify.
evidence
What the evidence for this route shows
Compounded NAD+ is not an FDA-approved product, and the route sold here has no randomised human trial behind it: there is no published study showing that subcutaneous or intranasal NAD+ raises blood NAD+ in people, let alone that it improves energy, focus or any aging endpoint. What the clinical literature actually supports is the oral precursor NR, which does raise blood NAD+ in controlled trials — a different molecule by a different route. Peter MD markets its protocol as "backed by 100+ clinical studies," but that is the company's own promotional language rather than a citation we could verify — the same evidence gap applies here as to every other injectable or intranasal NAD+ seller on this board.
pricing
What it actually costs
- advertised
- "$369" for 2 vials (200mg/ml), stated as an 8-10 week supply, printed on the NAD+ product page.
- you pay
- Roughly $147-184/month depending on how the 8-10 week supply is used — our own division of $369 by the stated supply window, not a figure Peter MD publishes as a monthly rate.
- the catch
- A package price for a multi-week supply rather than a subscription rate. Nothing on the product page converts $369 into a monthly figure or states how the injection frequency is meant to work across the 8-10 week window, so a reader has to do that math themselves rather than compare it directly against providers who publish a flat monthly number.
Other money you will meet
- Also sells tirzepatide, semaglutide, sermorelin and TRT — priced and billed separately from the NAD+ line
- No membership fee, lab fee or shipping cost is stated on the NAD+ product page we reviewed
source :: read at getpetermd.com on 2026-08-04, in a browser that runs JavaScript.
fit
Who this is and is not for
Buy it if
- You specifically want injectable NAD+ from a physician-prescribed telehealth provider
- You would rather pay once for a multi-week supply than commit to an ongoing monthly subscription
- You might also want tirzepatide, semaglutide, sermorelin or TRT from the same provider later
Look elsewhere if
- You want a single clean monthly price you can budget against without doing the math yourself
- You want a route other than injection — Peter MD's NAD+ line here is injectable, not nasal, oral or troche
- You want a named compounding pharmacy or a stated 503A/503B designation
- You live in a state Peter MD does not serve
included
What is inside the price
- consult
- Yes — Peter MD is physician-prescribed telehealth; a clinician review precedes the NAD+ prescription.
- labs
- Not stated on the product page we reviewed.
- follow-ups
- Not detailed on the product page we reviewed.
- human support
- Not detailed on the product page we reviewed.
- supplies
- Two 200mg/ml NAD+ vials per $369 order; whether needles/syringes are included is not stated on the page we reviewed.
- shipping
- Not detailed on the product page we reviewed.
the_knock
What they would rather you skipped
Peter MD's most visible marketing claim — that its NAD+ protocol is "backed by 100+ clinical studies" — is the company's own promotional language, not a citation to a specific study we could check, and it echoes the same category-wide gap this site documents elsewhere: injected NAD+ has no rigorous human trial evidence behind it, regardless of how many studies a seller says exist. The price itself has a similar shape: $369 for two vials is a package figure for an 8-10 week supply, not a monthly rate, so the $147-184/month range depends entirely on how quickly a patient works through the vials — a lever Peter MD's own product page never spells out the way some of the more transparent partners on this board do. Customer reviews of Peter MD are mixed, and the site names no compounding pharmacy and no 503A/503B designation.
And the rest
- Priced as an 8-10 week package ($369 for 2 vials) rather than a clean monthly figure — the $147-184/month range is our own math, not a number Peter MD states as a monthly rate
- The "backed by 100+ clinical studies" claim is Peter MD's own marketing language; we did not independently verify it, and injectable NAD+ still has no published human trial showing it raises blood NAD+ or improves any measurable outcome
- Not available in every state — coverage should be confirmed during intake, and this is not detailed on the pricing page itself
- Customer reviews are mixed, and no compounding pharmacy name or 503A/503B designation is published
- Peter MD pays us a commission if you start care through this page
tools
Work out your own number
Every figure on this page was read on Peter MD’s own site on 2026-08-04 in a browser that runs JavaScript, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.